Potential two-step proteomic signature for Parkinson's disease: Pilot analysis in the Harvard Biomarkers Study

INTRODUCTION: We sought to determine if our previously validated proteomic profile for detecting Alzheimer's disease would detect Parkinson's disease (PD) and distinguish PD from other neurodegenerative diseases. METHODS: Plasma samples were assayed from 150 patients of the Harvard Biomark...

Descripción completa

Detalles Bibliográficos
Autores principales: O'Bryant, Sid E., Edwards, Melissa, Zhang, Fan, Johnson, Leigh A., Hall, James, Kuras, Yuliya, Scherzer, Clemens R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Special Section: Blood-Based Biomarkers for Alzheimer's Disease & Related Dementias. (Editor: Henrik Zetterberg)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502745/
https://www.ncbi.nlm.nih.gov/pubmed/31080873
http://dx.doi.org/10.1016/j.dadm.2019.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502745/
https://www.ncbi.nlm.nih.gov/pubmed/31080873
http://dx.doi.org/10.1016/j.dadm.2019.03.001

Ejemplares similares